Cargando…
Complement therapy in atypical haemolytic uraemic syndrome (aHUS)
Central to the pathogenesis of atypical haemolytic uraemic syndrome (aHUS) is over-activation of the alternative pathway of complement. Inherited defects in complement genes and autoantibodies against complement regulatory proteins have been described. The use of plasma exchange to replace non-funct...
Autores principales: | Wong, Edwin K.S., Goodship, Tim H.J., Kavanagh, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pergamon Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899040/ https://www.ncbi.nlm.nih.gov/pubmed/23810412 http://dx.doi.org/10.1016/j.molimm.2013.05.224 |
Ejemplares similares
-
A systematic review of eculizumab for atypical haemolytic uraemic syndrome (aHUS)
por: Rathbone, John, et al.
Publicado: (2013) -
Atypical haemolytic uraemic syndrome associated with a CD46 mutation triggered by Shigella flexneri
por: Brocklebank, Vicky, et al.
Publicado: (2014) -
Genetics and complement in atypical HUS
por: Kavanagh, David, et al.
Publicado: (2010) -
Atypical Haemolytic Uraemic Syndrome Associated with a Hybrid Complement Gene
por: Venables, Julian P, et al.
Publicado: (2006) -
Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis
por: Fakhouri, Fadi, et al.
Publicado: (2021)